Related Experiment Video
Updated: Jan 24, 2026

Detection of Targetable Alterations in Non-small Cell Lung Cancer using Next-generation Sequencing
Published on: October 10, 2025
miR‑497 suppresses malignant phenotype in non‑small cell lung cancer via targeting KDR
Youyou Xia1, Chenxi Hu2, Lian Lian3
1Department of Oncology, The Affiliated Hospital of Kangda College of Nanjing Medical University, (The First People's Hospital of Lianyungang), Lianyungang, Jiangsu 222002, P.R. China.
Abstract:
The aim of the present study was to evaluate the expression of microRNA‑497 (miR‑497) in non‑small cell lung cancer (NSCLC) tissues and cell lines, and to investigate possible mechanisms associated with its regulatory role on cell behaviors. The expression level of miR‑497 was evaluated in 15 cases of NSCLC tissues and 8 adjacent normal tissues, and in 8 NSCLC cell lines, including H1975, A549, H358, H1650, H460, Calu‑1, H1299 and H292, by reverse transcription‑quantitative polymerase chain reaction. Effects of miR‑497 overexpression on cell proliferation, invasion, apoptosis and radiosensitivity were examined with a Cell Counting Kit‑8 assay, Matrigel assay, flow cytometry and a clone formation assay in vitro, respectively, and in an in vivo ectopic tumor nude mice model. A dual luciferase reporter assay was employed for interaction between miR‑497 and its target gene kinase insert domain receptor (KDR). A significantly decreased level of miR‑497 was determined in NSCLC tissues, compared with adjacent normal tissues, and Calu‑1 and H1975 exhibited the lowest miR‑497 expression among the 8 NSCLC cell lines. miR‑497 overexpression could inhibit cell proliferation and invasion, promote cancer cell apoptosis and decrease cell clone formation following radiation treatment in vitro, and decrease tumor growth in vivo. Furthermore, a dual luciferase reporter assay revealed that KDR as the target gene for miR‑497. It was demonstrated that miR‑497 was downregulated in NSCLC specimens. Additionally, miR‑497 directly targeted and downregulated KDR expression, and inhibited malignant behaviors of NSCLC cells. These data indicated that miR‑497 could serve as a tumor suppressor gene involved in NSCLC pathogenesis.
Insights
MicroRNA-497 (miR-497) is downregulated in non-small cell lung cancer (NSCLC). Overexpressing miR-497 inhibits tumor growth and malignant behaviors, suggesting its role as a tumor suppressor.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Non-small cell lung cancer (NSCLC) is a leading cause of cancer mortality worldwide.
- MicroRNAs (miRNAs) play crucial roles in cancer development and progression.
- The specific role of microRNA-497 (miR-497) in NSCLC remains to be fully elucidated.
Purpose of the Study:
- To evaluate the expression of miR-497 in NSCLC tissues and cell lines.
- To investigate the regulatory role of miR-497 in NSCLC cell behaviors.
- To identify potential mechanisms underlying miR-497's function in NSCLC.
Main Methods:
- Reverse transcription-quantitative polymerase chain reaction (RT-qPCR) for miR-497 expression analysis.
- In vitro assays (Cell Counting Kit-8, Matrigel, flow cytometry, clone formation) to assess cell proliferation, invasion, apoptosis, and radiosensitivity.
- In vivo ectopic tumor nude mice model for tumor growth evaluation.
- Dual luciferase reporter assay to confirm the interaction between miR-497 and its target gene, KDR.
Main Results:
- miR-497 expression was significantly decreased in NSCLC tissues compared to adjacent normal tissues.
- Overexpression of miR-497 inhibited NSCLC cell proliferation and invasion, promoted apoptosis, and reduced radiosensitivity.
- miR-497 directly targeted and downregulated Kinase Insert Domain Receptor (KDR) expression.
- In vivo studies showed that miR-497 overexpression decreased tumor growth.
Conclusions:
- miR-497 is downregulated in NSCLC, indicating its potential as a tumor suppressor.
- miR-497 exerts its tumor-suppressive effects by targeting KDR and inhibiting malignant behaviors.
- miR-497 holds promise as a therapeutic target or biomarker for NSCLC.
Related Concept Videos
Targeted Cancer Therapies
There are several types of targeted therapies against...
Lung Capacity
Target Cell Response to Hormones
Notably, the cellular response can be regulated by altering the number of receptors expressed in the cell. For example, prolonged exposure to elevated hormone levels results in a gradual decline or down-regulation in the number of receptors for that specific hormone on the cell surface. Conversely, in response to low hormone levels, cells may use up-regulation, producing an...
Acid Suppressive Drugs for Peptic Ulcer Disease: Antacids
However, this neutralization reaction between...
Cancer Cell Migration through Invadopodia
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...

